Menu
Recruiting NCT06367400

Validation of Pediatric Sleep Questionnaire on a Swedish Cohort

— Observational Obstructive Sleep Apnea Sleep Disorder Sleep Disorders in Children Obstructive Sleep Apnea of Child

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Pediatric Sleep Questionnaire.
Who it may be relevant to
Registry conditions: Obstructive Sleep Apnea, Sleep Disorder, Sleep Disorders in Children, Obstructive Sleep Apnea of Child. Basic parameters: 18 months — 15 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Sweden
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Validation of Pediatric Sleep Questionnaire, a Multi-center Study in Sweden

Overview

This study is aimed to validate the questionnaire called Pediatric Sleep Questionnaire on a Swedish cohort of children from 18 months to 15 years old with obstructive sleep disordered breathing.

Interventions

  • Diagnostic test Pediatric Sleep Questionnaire
    Questionnaire with 22 questions of symptoms of OSDB

Primary outcome measures

  • Level of baseline PSQ [Time frame: Baseline]
  • Changes of baseline PSQ after treatment [Time frame: 6 months to 12 months]
Secondary outcome measures (3)
  • PSQ vs OSA-18 [Time frame: 6 months]
  • PSQ vs. PSG [Time frame: 6 months]
  • PSQ levels of healthy controls vs children with OSDB [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Children with OSDB-symptoms referred to ENT-clinics
  • Age between 18 months and 15 years old.
  • Good knowledge of the Swedish language

Exclusion criteria

  • Craniofacial abnormalities
  • Mb Down
  • neuromuscular disorders
  • do not understand swedish

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Sweden · 1 center
  • Akademiska hospital — Uppsala

Identifiers

NCT: NCT06367400 · SwePSQ

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗